Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,053,314
+$97,490 QoQ
Shares Held
8,197
+3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,079
of 3,769 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SGL Investment Advisors, Inc. holds $12,818,442 across 8 Drug Manufacturers - General names. MRK ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,360 | $7,456,559 | |
| 2 | AMGN |
Amgen Inc
|
3,193 | $1,156,249 | |
| 3 | LLY |
ELI LILLY & Co
|
923 | $1,107,073 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,197 | $1,053,314 | |
| 5 | ABBV |
AbbVie Inc.
|
3,901 | $981,647 | |
| 6 | PFE |
Pfizer Inc
|
14,975 | $360,598 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,206 | $357,589 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,734 | $345,413 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,053,314 | 8,197 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $955,824 | 7,946 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $834,290 | 7,926 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $720,958 | 8,590 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $285,846 | 3,611 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $339,203 | 3,779 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $292,570 | 2,941 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||